Advertisement
Screener

uniQure N.V. (QURE) Increase (Decrease) in Accounts Payable

2.8 / 5 stars · 68/120 Roast Me

uniQure N.V. Increase (Decrease) in Accounts Payable

uniQure N.V. (QURE) reported Increase (Decrease) in Accounts Payable of -$557.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-05.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-05-05

  • uniQure N.V. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$557.00K.
  • uniQure N.V. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$1.02M, a 150.15% decline year-over-year.
  • uniQure N.V. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $649.00K, a 41.37% decline year-over-year.
  • uniQure N.V. increase (decrease) in accounts payable for the quarter ending 2025-06-30 was -$204.00K.
  • uniQure N.V. increase (decrease) in accounts payable for fiscal 2025 was -$2.67M, a 275.46% decline from fiscal 2024.
  • uniQure N.V. increase (decrease) in accounts payable for fiscal 2024 was $1.52M.
  • uniQure N.V. increase (decrease) in accounts payable for fiscal 2023 was -$4.17M, a 145.13% decline from fiscal 2022.
  • uniQure N.V. increase (decrease) in accounts payable for fiscal 2022 was $9.24M.
Period endIncrease (Decrease) in Accounts Payable 3 monthIncrease (Decrease) in Accounts Payable 6 monthIncrease (Decrease) in Accounts Payable 9 monthIncrease (Decrease) in Accounts Payable 12 month
2026-03-31-$557.00K
10-Q · filed 2026-05-05
-$1.58M
derived: sum of 2 quarters · filed 2026-05-05
-$927.00K
derived: sum of 3 quarters · filed 2026-05-05
-$1.13M
derived: sum of 4 quarters · filed 2026-05-05
2025-12-31-$1.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02
-$370.00K
derived: sum of 2 quarters · filed 2026-03-02
-$574.00K
derived: sum of 3 quarters · filed 2026-03-02
-$2.67M
10-K · filed 2026-03-02
2025-09-30$649.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10
$445.00K
derived: sum of 2 quarters · filed 2025-11-10
-$1.65M
10-Q · filed 2025-11-10
$384.00K
derived: sum of 4 quarters · filed 2026-05-05
2025-06-30-$204.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29
-$2.30M
10-Q · filed 2025-07-29
-$265.00K
derived: sum of 3 quarters · filed 2026-05-05
$842.00K
derived: sum of 4 quarters · filed 2026-05-05
2025-03-31-$2.09M
10-Q · filed 2026-05-05
-$61.00K
derived: sum of 2 quarters · filed 2026-05-05
$1.05M
derived: sum of 3 quarters · filed 2026-05-05
$128.00K
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31$2.03M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02
$3.14M
derived: sum of 2 quarters · filed 2026-03-02
$2.22M
derived: sum of 3 quarters · filed 2026-03-02
$1.52M
10-K · filed 2026-03-02
2024-09-30$1.11M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10
$189.00K
derived: sum of 2 quarters · filed 2025-11-10
-$512.00K
10-Q · filed 2025-11-10
$103.00K
derived: sum of 4 quarters · filed 2026-03-02
2024-06-30-$918.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29
-$1.62M
10-Q · filed 2025-07-29
-$1.00M
derived: sum of 3 quarters · filed 2026-03-02
-$4.58M
derived: sum of 4 quarters · filed 2026-03-02
2024-03-31-$701.00K
10-Q · filed 2025-05-09
-$86.00K
derived: sum of 2 quarters · filed 2026-03-02
-$3.66M
derived: sum of 3 quarters · filed 2026-03-02
-$3.21M
derived: sum of 4 quarters · filed 2026-03-02
2023-12-31$615.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02
-$2.96M
derived: sum of 2 quarters · filed 2026-03-02
-$2.51M
derived: sum of 3 quarters · filed 2026-03-02
-$4.17M
10-K · filed 2026-03-02
2023-09-30-$3.57M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05
-$3.12M
derived: sum of 2 quarters · filed 2024-11-05
-$4.78M
10-Q · filed 2024-11-05
-$75.00K
derived: sum of 4 quarters · filed 2025-02-27
2023-06-30$449.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01
-$1.21M
10-Q · filed 2024-08-01
$3.50M
derived: sum of 3 quarters · filed 2025-02-27
$394.00K
derived: sum of 4 quarters · filed 2025-02-27
2023-03-31-$1.66M
10-Q · filed 2024-05-07
$3.05M
derived: sum of 2 quarters · filed 2025-02-27
-$55.00K
derived: sum of 3 quarters · filed 2025-02-27
$271.00K
derived: sum of 4 quarters · filed 2025-02-27
2022-12-31$4.71M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
$1.61M
derived: sum of 2 quarters · filed 2025-02-27
$1.93M
derived: sum of 3 quarters · filed 2025-02-27
$9.24M
10-K · filed 2025-02-27
2022-09-30-$3.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
-$2.78M
derived: sum of 2 quarters · filed 2023-11-07
$4.53M
10-Q · filed 2023-11-07
$1.80M
derived: sum of 4 quarters · filed 2024-02-28
2022-06-30$326.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01
$7.63M
10-Q · filed 2023-08-01
$4.90M
derived: sum of 3 quarters · filed 2024-02-28
-$3.54M
derived: sum of 4 quarters · filed 2024-02-28
2022-03-31$7.31M
10-Q · filed 2023-05-09
$4.58M
derived: sum of 2 quarters · filed 2024-02-28
-$3.87M
derived: sum of 3 quarters · filed 2024-02-28
$4.07M
derived: sum of 4 quarters · filed 2024-02-28
2021-12-31-$2.73M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28
-$11.17M
derived: sum of 2 quarters · filed 2024-02-28
-$3.24M
derived: sum of 3 quarters · filed 2024-02-28
-$727.00K
10-K · filed 2024-02-28
2021-09-30-$8.44M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02
-$507.00K
derived: sum of 2 quarters · filed 2022-11-02
$2.00M
10-Q · filed 2022-11-02
$3.03M
derived: sum of 4 quarters · filed 2023-02-27
2021-06-30$7.93M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08
$10.44M
10-Q · filed 2022-08-08
$11.47M
derived: sum of 3 quarters · filed 2023-02-27
$8.72M
derived: sum of 4 quarters · filed 2023-02-27
2021-03-31$2.51M
10-Q · filed 2022-05-02
$3.53M
derived: sum of 2 quarters · filed 2023-02-27
$790.00K
derived: sum of 3 quarters · filed 2023-02-27
$355.00K
derived: sum of 4 quarters · filed 2023-02-27
2020-12-31$1.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27
-$1.72M
derived: sum of 2 quarters · filed 2023-02-27
-$2.15M
derived: sum of 3 quarters · filed 2023-02-27
-$2.70M
10-K · filed 2023-02-27
2020-09-30-$2.74M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-25
-$3.18M
derived: sum of 2 quarters · filed 2021-10-25
-$3.72M
10-Q · filed 2021-10-25
-$1.65M
derived: sum of 4 quarters · filed 2022-02-25
2020-06-30-$435.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-26
-$981.00K
10-Q · filed 2021-07-26
$1.09M
derived: sum of 3 quarters · filed 2022-02-25
$388.00K
derived: sum of 4 quarters · filed 2022-02-25
2020-03-31-$546.00K
10-Q · filed 2021-05-10
$1.52M
derived: sum of 2 quarters · filed 2022-02-25
$823.00K
derived: sum of 3 quarters · filed 2022-02-25
$1.35M
derived: sum of 4 quarters · filed 2022-02-25
2019-12-31$2.07M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25
$1.37M
derived: sum of 2 quarters · filed 2022-02-25
$1.90M
derived: sum of 3 quarters · filed 2022-02-25
$1.65M
10-K · filed 2022-02-25
2019-09-30-$701.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-27
-$172.00K
derived: sum of 2 quarters · filed 2020-10-27
-$418.00K
10-Q · filed 2020-10-27
-$642.00K
derived: sum of 4 quarters · filed 2021-03-01
2019-06-30$529.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30
$283.00K
10-Q · filed 2020-07-30
$59.00K
derived: sum of 3 quarters · filed 2021-03-01
$631.00K
derived: sum of 4 quarters · filed 2021-03-01
2019-03-31-$246.00K
10-Q · filed 2020-04-29
-$470.00K
derived: sum of 2 quarters · filed 2021-03-01
$102.00K
derived: sum of 3 quarters · filed 2021-03-01
$138.00K
derived: sum of 4 quarters · filed 2021-03-01
2018-12-31-$224.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01
$348.00K
derived: sum of 2 quarters · filed 2021-03-01
$384.00K
derived: sum of 3 quarters · filed 2021-03-01
$1.06M
10-K · filed 2021-03-01
2018-09-30$572.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-28
$608.00K
derived: sum of 2 quarters · filed 2019-10-28
$1.29M
10-Q · filed 2019-10-28
$1.06M
derived: sum of 4 quarters · filed 2020-03-02
2018-06-30$36.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-29
$717.00K
10-Q · filed 2019-07-29
$487.00K
derived: sum of 3 quarters · filed 2020-03-02
$381.00K
derived: sum of 4 quarters · filed 2020-03-02
2018-03-31$681.00K
10-Q · filed 2019-04-29
$451.00K
derived: sum of 2 quarters · filed 2020-03-02
$345.00K
derived: sum of 3 quarters · filed 2020-03-02
-$306.00K
derived: sum of 4 quarters · filed 2020-03-02
2017-12-31-$230.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02
-$336.00K
derived: sum of 2 quarters · filed 2020-03-02
-$987.00K
derived: sum of 3 quarters · filed 2020-03-02
-$1.67M
10-K · filed 2020-03-02
2017-09-30-$106.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06
-$757.00K
derived: sum of 2 quarters · filed 2018-11-06
-$1.44M
10-Q · filed 2018-11-06
-$1.13M
derived: sum of 4 quarters · filed 2019-02-28
2017-06-30-$651.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08
-$1.33M
10-Q · filed 2018-08-08
-$1.02M
derived: sum of 3 quarters · filed 2019-02-28
$878.00K
derived: sum of 4 quarters · filed 2019-02-28
2017-03-31-$683.00K
10-Q · filed 2018-04-30
-$371.00K
derived: sum of 2 quarters · filed 2019-02-28
$1.53M
derived: sum of 3 quarters · filed 2019-02-28
-$1.53M
derived: sum of 4 quarters · filed 2019-02-28
2016-12-31$312.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
$2.21M
derived: sum of 2 quarters · filed 2019-02-28
-$847.00K
derived: sum of 3 quarters · filed 2019-02-28
$344.00K
10-K · filed 2019-02-28
2016-09-30$1.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01
-$1.16M
derived: sum of 2 quarters · filed 2017-11-01
$32.00K
10-Q · filed 2017-11-01
2016-06-30-$3.06M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08
-$1.87M
10-Q · filed 2017-08-08
2016-03-31$1.19M
10-Q · filed 2017-05-09
2015-12-31-$774.00K
10-K · filed 2018-03-14
2014-12-31-$321.00K
10-K · filed 2017-03-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
SELLAS Life Sciences Group, Inc. (SLS)United States$2.420B-91.87
Vera Therapeutics, Inc. (VERA)United States$2.402B-7.67
Harmony Biosciences Holdings, Inc. (HRMY)United States$2.399B11.67
Nurix Therapeutics, Inc. (NRIX)United States$2.457B-5.39
Mineralys Therapeutics, Inc. (MLYS)United States$2.353B-6.82
Viridian Therapeutics, Inc.\DE (VRDN)United States$2.342B-5.38
SUPERNUS PHARMACEUTICALS, INC. (SUPN)United States$2.517B-24.63
Immunome Inc. (IMNM)United States$2.538B-9.45
Disc Medicine, Inc. (IRON)United States$2.553B-11.40
Zai Lab Ltd (ZLAB)$2.241B-113.34